Abstract: A method and composition for the treatment of hormone allergy is disclosed. The method relates to using progesterone dilutions, or any other steroid hormone, to treat the systemic symptoms of hormone allergy, including pain. The composition of the hormone dilutions ranges from 10?1 to 10?5. The hormone dilution may be administered sublingually, or, in the alternative, an intradermal route of administration may be chosen. Hormone dilutions may be administered at daily intervals or on any other treatment schedule as required to alleviate a patient's symptoms.

Abstract: The present disclosure provides methods and compositions for diagnosis and treatment of hormone allergy in a subject, including, without limitation, through measurement of elevated anti-hormone antibodies, e.g., IgE, IgG, and IgM. Target hormones may include estrogen and progesterone. Hormone allergy related symptoms and disorders may be treated by administration of dilute hormone solutions, such as dilute estrogen or progesterone solutions, intradermally or sublingually.

Abstract: Compositions and/or methods are provided for treating multiple sclerosis and/or an autoimmune condition comprising administering to a human an effective amount of a hormone dilution.

Abstract: Compositions and/or methods are provided for treating macular degeneration and/or a degenerative ocular condition comprising administering to a human an effective amount of a hormone dilution.

Abstract: A method and composition for the treatment of infertility is disclosed. The method relates to using progesterone dilutions, or any other steroid hormone, to treat infertility. The hormone dilution may be administered sublingually, by drops or sublingual tablet or, an intradermal route of administration may be chosen.